Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial.
Saved in:
| Title: | Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial. |
|---|---|
| Authors: | Chen YD; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., He ZY; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Zhao WJ; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., He YH; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., Liu YH; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Zhu YJ; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., Yu YY; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., Xiao ZZ; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., Chang XS; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China., Liu ZB; Shenzhen Zigzag Biotechnology Co., Ltd., China., Zhang HB; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.; State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. |
| Source: | Integrative cancer therapies [Integr Cancer Ther] 2026 Jan-Dec; Vol. 25, pp. 15347354251396002. Date of Electronic Publication: 2026 Mar 11. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 101128834 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-695X (Electronic) Linking ISSN: 15347354 NLM ISO Abbreviation: Integr Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41810508 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chen+YD%22">Chen YD</searchLink>; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China.<br /><searchLink fieldCode="AU" term="%22He+ZY%22">He ZY</searchLink>; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhao+WJ%22">Zhao WJ</searchLink>; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China.<br /><searchLink fieldCode="AU" term="%22He+YH%22">He YH</searchLink>; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China.<br /><searchLink fieldCode="AU" term="%22Liu+YH%22">Liu YH</searchLink>; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhu+YJ%22">Zhu YJ</searchLink>; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China.<br /><searchLink fieldCode="AU" term="%22Yu+YY%22">Yu YY</searchLink>; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China.<br /><searchLink fieldCode="AU" term="%22Xiao+ZZ%22">Xiao ZZ</searchLink>; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China.<br /><searchLink fieldCode="AU" term="%22Chang+XS%22">Chang XS</searchLink>; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China.<br /><searchLink fieldCode="AU" term="%22Liu+ZB%22">Liu ZB</searchLink>; Shenzhen Zigzag Biotechnology Co., Ltd., China.<br /><searchLink fieldCode="AU" term="%22Zhang+HB%22">Zhang HB</searchLink>; The Second Clinical College of Guangzhou University of Chinese Medicine, China.; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangzhou Key Laboratory of Acupuncture and Medicine Research, China.; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.; State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou, China.; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101128834%22">Integrative cancer therapies</searchLink> [Integr Cancer Ther] 2026 Jan-Dec; Vol. 25, pp. 15347354251396002. <i>Date of Electronic Publication: </i>2026 Mar 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial Protocol – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101128834 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-695X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215347354%22">15347354 </searchLink><i>NLM ISO Abbreviation: </i>Integr Cancer Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41810508 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/15347354251396002 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 15347354251396002 Titles: – TitleFull: Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen YD – PersonEntity: Name: NameFull: He ZY – PersonEntity: Name: NameFull: Zhao WJ – PersonEntity: Name: NameFull: He YH – PersonEntity: Name: NameFull: Liu YH – PersonEntity: Name: NameFull: Zhu YJ – PersonEntity: Name: NameFull: Yu YY – PersonEntity: Name: NameFull: Xiao ZZ – PersonEntity: Name: NameFull: Chang XS – PersonEntity: Name: NameFull: Liu ZB – PersonEntity: Name: NameFull: Zhang HB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan-Dec Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1552-695X Numbering: – Type: volume Value: 25 Titles: – TitleFull: Integrative cancer therapies Type: main |
| ResultId | 1 |
